Recursion (NASDAQ:RXRX) reported fourth-quarter 2025 revenue of $35.5 million on Wednesday, significantly exceeding analyst estimates of $24.6 million. The performance was driven by the timing of ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...

Volvo Group North America disclosed that it suffered an indirect data breach stemming from the compromise of IT systems at American business services giant Conduent, of which Volvo is a customer.

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

The organization says cross-border trade in steel-containing products reached 410 million metric tons in 2024. In addition to keeping finished and semi-finished steel trading data, Worldsteel now ...

From data poisoning to prompt injection, threats against enterprise AI applications and foundations are beginning to move from theory to reality. Attacks against AI systems and infrastructure are ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Nasdaq-listed VivoPower (VVPR) is expanding its XRP-linked strategy through a new joint venture that aims to acquire hundreds of millions of dollars worth of Ripple Labs shares, giving investors ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...